The effect of vitamin D supplementation on insulin resistance and arterial stiffness in patients with hypothyroidism

Main Article Content

I.V. Pankiv

Abstract

Background. Recent epidemiological studies revealed a significant inverse relationship between vitamin D levels, insulin resistance (IR), and cardiovascular diseases. However, few interventional studies have evaluated the effect of vitamin D supplementation on cardiovascular risk, such as IR and arterial stiffness in hypothyroidism. The purpose of the study is to investigate the role of vitamin D supplementation on cardiovascular risk in patients with hypothyroidism, including metabolic parameters, IR, and arterial stiffness. Materials and methods. We enrolled 55 patients with hypothyroidism who were taking levothyroxine medications. We excluded patients who were taking vitamin D or calcium supplements. Participants were randomized into the vitamin D group (cholecalciferol 4,000 IU/day, n = 30) or the control group (only levothyroxine, n = 25). We compared their IR (homeostatic model assessment (HOMA-IR)) and arterial stiffness (brachial-ankle pulse wave velocity) before and after 12 weeks of intervention. Results. The baseline characteristics of the two groups were similar. A total of 55 participants completed the study protocol. At the end of the study period, 25-hydroxyvitamin D (25(OH)D) levels were significantly higher in the vitamin D group than in the control group (32.7 ± 7.2 ng/ml vs. 17.1 ± 6.3 ng/ml, p < 0.05). There was no difference in HOMA-IR or changes in arterial stiffness between the groups. Conclusions. Our data suggest that vitamin D supplementation might be effective in terms of elevating 25(OH)D levels. However, we identified no beneficial effects on cardiovascular risk in hypothyroidism, including IR and arterial stiffness.

Article Details

How to Cite
Pankiv, I. “The Effect of Vitamin D Supplementation on Insulin Resistance and Arterial Stiffness in Patients With Hypothyroidism”. INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine), vol. 14, no. 7, Dec. 2018, pp. 668-72, doi:10.22141/2224-0721.14.7.2018.148774.
Section
Original Researches

References

Toulis K, Tsekmekidou X, Potolidis E, et al. Thyroid autoimmunity in the context of type 2 diabetes mellitus: implications for vitamin D. Int J Endocrinol. 2015;2015:710363. doi: 10.1155/2015/710363.

Mackawy AM, Al-Ayed BM, Al-Rashidi BM. Vitamin D deficiency and its association with thyroid disease. Int J Health Sci (Qassim). 2013 Nov;7(3):267-75.

Carlson CR Jr, Uriu-Adams JY, Chambers CD, et al. Vitamin D Deficiency in Pregnant Ukrainian Women: Effects of Alcohol Consumption on Vitamin D Status. J Am Coll Nutr. 2017 Jan;36(1):44-56. doi: 10.1080/07315724.2016.1174091.

Wang J, Li S, Chen G, et al. Meta-analysis of the association between vitamin D and autoimmune thyroid disease. Nutrients. 2015 Apr 3;7(4):2485-98. doi: 10.3390/nu7042485.

As Al-Shoumer K, Al-Essa TM. Is there a relationship between vitamin D with insulin resistance and diabetes mellitus. World J Diabetes. 2015 Jul 25;6(8):1057-64. doi: 10.4239/wjd.v6.i8.1057.

Díez JJ, Iglesias P. An analysis of the relative risk for hypothyroidism in patients with Type 2 diabetes Diabet Med. 2012 Dec;29(12):1510-4. doi: 10.1111/j.1464-5491.2012.03687.x.

Ertek S, Akgul E, Cicero AF, et al. 25-Hydroxy vitamin D levels and endothelial vasodilator function in normotensive women. Arch Med Sci. 2012 Feb 29;8(1):47-52. doi: 10.5114/aoms.2012.27280.

Anderson JL, May HT, Horne BD, et al. Relation of vitamin D deficiency to cardiovascular risk factors, disease status, and incident events in a general healthcare population. Am J Cardiol. 2010 Oct 1;106(7):963-8. doi: 10.1016/j.amjcard.2010.05.027.

Karakas M, Thorand B, Zierer A, et al. Low levels of serum 25-hydroxyvitamin D are associated with increased risk of myocardial infarction, especially in women: results from the MONICA/KORA Augsburg case-cohort study. J Clin Endocrinol Metab. 2013 Jan;98(1):272-80. doi: 10.1210/jc.2012-2368.

Vacek JL, Vanga SR, Good M, Lai SM, Lakkireddy D, Howard PA. Vitamin D deficiency and supplementation and relation to cardiovascular health. Am J Cardiol. 2012 Feb 1;109(3):359-63. doi: 10.1016/j.amjcard.2011.09.020.

Wang TJ, Pencina MJ, Booth SL, et al. Vitamin D deficiency and risk of cardiovascular disease. Circulation. 2008 Jan 29;117(4):503-11. doi: 10.1161/CIRCULATIONAHA.107.706127.

Pludowski P, Grant WB, Bhattoa HP, et al. Vitamin D Status in Central Europe. Int J Endocrinol. 2014;2014:589587. doi: 10.1155/2014/589587.

Duntas LH, Orgiazzi J, Brabant G. The interface between thyroid and diabetes mellitus. Clin Endocrinol (Oxf). 2011 Jul;75(1):1-9. doi: 10.1111/j.1365-2265.2011.04029.x.

Witham MD, Dore FJ, Druburgh M, Sugden JA, Morris AD, Struthers AD. The effect of different doses of vitamin D3 on markers of vascular health. Diabetologia. 2010 Oct;53(10):2112-9. doi: 10.1007/s00125-010-1838-1.

von Hurst PR, Stonehouse W, Coad J. Vitamin D supplementation reduces insulin resistance in South Asian women living in New Zealand who are insulin resistant and vitamin D deficient: a randomised, placebo-controlled trial. Br J Nutr. 2010 Feb;103(4):549-55. doi: 10.1017/S0007114509992017.

Wood AD, Secombes KR, Thies F, et al. Vitamin D3 supplementation has no effect on conventional cardiovascular risk factors: a parallel-group, double-blind, placebo-controlled RCT. J Clin Endocrinol Metab. 2012 Oct;97(10):3557-68. doi: 10.1210/jc.2012-2126.

Pittas AG, Harris SS, Stark PC, Dawson-Hughes B. The effects of calcium and vitamin D supplementation on blood glucose and markers of inflammation in non-diabetic adults. Diabetes Care. 2007 Apr;30(4):980-6. doi: 10.2337/dc06-1994.

Nagpal J, Pande JN, Bhartia A. A double-blind, randomized, placebo-controlled trial of the short-term effect of vitamin D3 supplementation on insulin sensitivity in apparently healthy, middle-aged, centrally obese men. Diabet Med. 2009 Jan;26(1):19-27. doi: 10.1111/j.1464-5491.2008.02636.x.

Most read articles by the same author(s)

1 2 3 4 > >>